UCL and Tech City UK is launching the Digital
Business Academy, the world’s first government-supported online learning
platform to provide digital and business skills for anyone aspiring to start,
grow or join a digital business. The programme is open to all UK residents and
requires no pre-qualification.
Read full article
First patient dosed in trial of novel T-cell therapy for leukaemia Milestone for Cell Therapy Catapult, UCL Business & Imperial Innovations partnership
The first acute myeloid leukaemia patient has been dosed in a Phase I/ll cell therapy trial1 being undertaken by Catapult Therapy TCR Ltd, a partnership established in July 2014 to accelerate development of a novel T cell receptor (TCR) therapy. The trial is expected to involve five centres in the UK, and is to assess the safety and efficacy of the therapy, which targets diseases associated with overexpression of the WT1 antigen. Catapult Therapy TCR Ltd is an innovative partnership between the Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation’s health and wealth, UCL Business (UCLB) and Imperial Innovations. More...
BaseStone, a UCL startup established by Alex Siljanovski – a graduate of UCL’s MSc Technology Entrepreneurship programme – has won the ‘Smart Cities’ pitch competition whilst on a market visit to Singapore organised by the UK Trade & Investment (UKTI). More...
By Stephen Caddick, Vice-Provost (Enterprise) at UCL
THE AWARD of the Nobel Prize in Physiology or Medicine this week to London-based professor John O’Keefe, along with his colleagues Moser and Moser, is well-deserved recognition for truly ground-breaking science – science which, in time, could have profound ramifications for the way we understand and treat neurological diseases like Alzheimer’s.
The recent success of Imperial College in realising £10m cash in exchange for a 10 per cent share holding in Imperial Innovations shows the continued market interest in the commercialisation of university research (report, 24 June).
[Re: Why Britain’s scientists are failing at business, Friday]
Tim Farron is right to highlight some of the challenges facing all entrepreneurs in this country, but the idea that Britain’s scientific community is failing at business is simply not accurate. More...